This journal is
indexed in Scopus

Year 2012 Vol. 20 No 3




EE Belarusian State Medical University, Minsk,
The Republic of Belarus

The primary aim of the cell encapsulation technology is the addressed delivery of the synthesized molecules to the target organ. The principle of the cell immunoisolation is the backgrounds of this method prior to transplantation donor cells are set in the semi-permeable membrane to protect them against their interaction with the hosts immune system. This membrane is selectively permeable to transport the nutrients and the products of the cellular secretion but relatively impermeable to larger molecules and cells of the hosts immune system. Besides the most immunoisolating devices have the internal matrix which contributes to the compact immobilization of cells inside the capsule. The proper choice of the synthetic materials and methods of their processing influences significantly the functioning efficacy of the semi-permeable membrane and matrix components. Up-to-date immunoisolating devices permit to reconstruct natural three-dimensional tissue environment thus maintaining functional activity and viability of the encapsulated cells. This review summarizes recent developments in the field of materials production used to make devices for cell encapsulation.

Keywords: cells, microencapsulation, macroencapsulation, alginate-polylysine capsules, transplantation
p. 100 116 of the original issue

1. Lanza RP, Chick WL. Transplantation of encapsulated cells and tissues. Surgery. 1997;121:19.
2. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: a commentary. Xenotransplantation. 2003;10(4):29399.
3. Rokstad AM, Holtan S, Strand B, Steinkjer B, Ryan L, Kulseng B, Skjak-Braek G, Espevik T. Microencapsulation of cells producing therapeutic proteins; optimizing cell growth and secretion. Cell Transplant. 2002;11(4):31324.
4. Anthony T, Fong P, Goyal A, Saltzman WM, Moss RL, Breuer C. Development of a parathyroid hormonecontrolled release system as a potential surgical treatment for hypoparathyroidism. J Pediatr Surg. 2005 Jan;40(1):815.
5. Roberts T, De Boni U, Sefton MV. Dopamine secretion by PC12 cells microencapsuled in a
hydroxyethyl methacrylatemethyl methacrylate copolymer. Biomaterials. 1996 Feb;17(3):26775.
6. Aebischer P, Goddard M, Signore A. Functional recovery in hemiparkinsonian primates transplanted with polymerencapsulated PC12 cells. Exp Neurol. 1994;126:15158.
7. Zimmermann H, Ehrhart F, Zimmermann D,
Muller K, Katsen-Globa A, Behringer M, Feilen PJ, Gessner P, Zimmermann G, Shirley SG, Weber MM, Metze J, Zimmermann U. Hydrogel-based encapsulation of biological, functional tissue: fundamentals, technologies and applications. Appl Phys A-Mater Sci Process. 2007;89:90922.
8. Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH. Implants of encapsulated human CNTFproducing ?broblasts prevent behavioral de?cits and striatal degeneration in a rodent model of Huntingtons disease. J Neurosci. 1996 Aug 15;16(16):516881.
9. Sagen J, Wang H, Tresco PA, Aebischer P. Transplants of immunologically isolated xenogeneic chromaf?n cells provide a longterm source of painreducing neuroactive substances. J Neurosci. 1993 Jun;13(6):241523.
10. Hammang JP, Emerich DF, Winn SR, Lee A, Lindner MD, Gentile FT, Doherty EJ, Kordower JH, Baetge EE. Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases. Cell Transplant. 1995;4(Suppl. 1):S278.
11. Li RH. Materials for immunoisolated cell transplantation. Advanced Drug Delivery Reviews. 1998;33:87109.
12. Robertson R, Sutherland D. Pancreas transplantation as therapy for diabetes mellitus. Annu Rev Med. 1992;43:39515.
13. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL. Results of our ?rst nine intraportal islet allografts in type I, insulindependent diabetic patients. Transplantation. 1991 Jan;51(1):7685.
14. Jauregui H, Chowdhury N, Chowdhury J. Use of mammalian liver cells for arti?cial liver support. Cell Transplant. 1996 May-Jun;5(3):35367.
15. Hymer WC, Wilbur DL, Page R, Hibbard E, Kelsey RC, Hatfield JM. Pituitary hollow ?ber units in vivo and vitro. Neuroendocrinology. 1981 Jun;32(6):33949.
16. Nawrot I, Wozniewicz B, Tolloczko T, Sawicki A, Gorski A, Chudzinski W, Wojtaszek M, Grzesiuk W, Sladowski D, Karwacki J, Zawitkowska T, Szmidt J. Allotransplantation of cultured parathyroid progenitor cells without immunosuppression: clinical results. Transplantation. 2007 Mar 27;83(6):73440.
17. Torregrosa NM, Rodriguez JM, Llorente S, Balsalobre MD, Rios A, Jimeno L, Parrilla P. Definitive treatment for persistent hypoparathyroidism in a kidney transplant patient: parathyroid allotransplantation. Thyroid. 2005 Nov;15(11):1299302.
18. Christenson L, Aebischer P, Galletti P. Encapsulated thymic epithelial cells as a potential treatment for immunode?ciences. ASAIO Trans. 1988 Jul-Sep;34(3):68186.
19. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994 Apr 16;343(8903):95051.
20. Chang TMS, Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Mol Med Today. 1998 May;4(5):22127.
21. Sefton MV, Dawson RM, Broughton RL, Blysniuk J, Sugamori ME. Microencapsulation of mammalian cells in a waterinsoluble polyacrylate by coextrusion and interfacial precipitation. Biotechnol Bioeng. 1987 Jun;29(9):113543.
22. Babensee J, Sefton M. Allogeneic and xenogeneic transplantation of HEMAMMA microencapsulated hepatoma cells into rats. Cell Transplant. 1996;5:56.
23. Lim F, Sun AM. Microencapsulated islets as bioarti?cial endocrine pancreas. Science. 1980;210:90810.
24. al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts an alternate approach to somatic gene therapy. Hum Gene Ther. 1995 Feb;6(2):16575.
25. De Haan BJ, Faas MM, De Vos P. Factors in?uencing insulin secretion from encapsulated islets. Cell Transplant. 2003;12:61725.
26. Dixit V, Gitnick G. Transplantation of microencapsulated hepatocytes for liver function replacement. J Biomater Sci Polymer Ed. 1995;7;34357.
27. Winn SR, Tresco PA. Hydrogel applications for encapsulated cellular transplants. Methods Neurosci. 1994;21:387402.
28. Aebischer P, Goddard M, Tresco PA; Goosen MFA, ed. Cell encapsulation for the nervous system. Fundamentals of Animal Cell Encapsulation and Immobilization. CRC Press, Boca Raton FL; 1993. . 741.
29. Silva AI, de Matos AN, Brons IG, Mateus M. An overview on the development of a bioartificial pancreas as a treatment of insulindependent diabetes mellitus. Med Res Rev. 2006 Mar;26(2):18122.
30. Zekorn T, Siebers U, Horcher A, Schnettler R, Klock G, Bretzel RG, Zimmermann U, Federlin K. Bariumalginate beads for immunoisolated transplantation of islets of Langerhans. Transplant Proc. 1992 Jun;24(3):93739.
31. Lacik I. Polymer chemistry in diabetes treatment by encapsulated islets of Langerhans: Review to 2006. Aust J Chem. 2006;59:50824.
32. Iwata H, Takagi T, Amemiya H, Shimizu H, Yamashita K, Kobayashi K, Akutsu T. Agarose for a bioarti?cial pancreas. J Biomed Mater Res. 1992 Jul;26(7):96777.
33. Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev. 2000;42:2964.
34. Yang H, Iwata H, Shimizu H, Takagi T, Tsuji T, Ito F. Comparative studies of in vitro and in vivo function of threedifferent shaped bioarti?cial pancreases made of agarosehydrogel. Biomaterials. 1994 Jan;15(2):11320.
35. Tun T, Inoue K, Hayashi H, Aung T, Gu YJ, Doi R, Kaji H, Echigo Y, Wang WJ, Setoyama H, Imamura M, Maetani S, Morikawa N, Iwata H, Ikada Y. A newly developed threelayer agarose microcapsule for a promising biohybrid arti?cial pancreas: rat to mouse xenotransplantation. Cell Transplant. 1996 Sep-Oct;5(5 Suppl. 1):S5963.
36. Hayashi H, Inoue , Aung T, Tun T, Yuanjun G, Wenjing W, Shinohara S, Kaji H, Doi R, Setoyama H, Kato M, Imamura M, Maetani S, Morikawa N, Iwata H, Ikada Y, Miyazaki J. Application of a novel cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: an in vitro study. Cell Transplant. 1996 Sep-Oct;5(5 Suppl. 1):S659.
37. Iwata H, Amemiya H, Hayashi R, Fujii S, Akutsu T. The use of photocrosslinkable polyvinyl alcohol in the immunoisolation of pancreatic islets. Transplant Proc. 1990 Apr;22(2):79779.
38. Cheung S, Tai J, Tze W. Effect of molecular weight exclusion of polysulfone ?bres on macroencapsulated pig islet xenograft function in diabetic mice. Cell Transplant. 1996;5:55.
39. Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, McDermott P, Baetge EE, Kordower JH. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature. 1997 Mar 27;386(6623):39599.
40. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. Implants of polymerencapsulated human NGFsecreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol. 1994 Nov 1;349(1):14864.
41. Buchser E, Goddard M, Heyd B, Joseph JM, Favre J, de Tribolet N, Lysaght M, Aebischer P. Immunoisolated xenogeneic chromaf?n cell therapy for chronic pain. Initial clinical experience. Anesthesiology. 1996 Nov;85(5):100512; discussion 29A30A.
42. Lanza R, Beyer A, Chick W. Xenogeneic humoral response to islets transplanted in biohybrid diffusion chambers. Transplantation. 1994;57:137175.
43. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science. 1991 Dec 20;254(5039):178284.
44. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE. Protection of encapsulated human islets implanted without im- munosuppression in patients with Type I or Type II diabetes an in nondiabetic control subjects. Diabetes. 1994 Sep;43(9):116770.
45. Deglon N., Henri A., Rouyer-Fessard P., Naffakh N., Beuzard Y., Aebischer P. Continuous delivery of erythropoietin in mice using encapsulated genetically engineered cell lines. Cell Transplant. 1996;5:52.
46. Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE. Intrathecal delivery of CNTF using encapsulated genetically modi?ed xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med. 1996 Jun;2(6):69699.
47. Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev. 2006;58:19443.
48. Yang MB, Vacanti JP, Ingber DE. Hollow ?bers for hepatocyte encapsulation and transplantation: studies of survival and function in rats. Cell Transplant. 1994;3:37385.
49. Kessler L, Legeay G, Jesser C, Damge C, Pinget M. In?uence of corona surface treatment on the properties of an arti?cial membrane used for Langerhans islets encapsulation: permeability and biocompatibility studies. Biomaterials. 1995 Feb;16(3):18591.
50. Ward RS, White KA, Wolcott CA, Wang AY, Kuhn RW, Taylor JE, John JK.
Development of a hybrid arti?cial pancreas with a dense polyurethane membrane. ASAIO J. 1993 Jul-Sep;39(3):M2617.
51. Omer A, Duvivier-Kali V, Fernandes J, Tchipashvili V, Colton CK, Weir GC.
Longterm normoglycemia in rats receiving transplants with encapsulated islets. Transplantation. 2005 Jan 15;79(1):528.
52. Takebe K, Shimura T, Munkhbat B, Hagihara M, Nakanishi H, Tsuji K. Xenogeneic (pig to rat) fetal liver fragment transplantation using macrocapsules for immunoisolation. Cell Transplant. 1996 Sep-Oct;5(5 Suppl. 1):S313.
53. Orive G, Hernandez RM, Gascon AR, Igartua M, Pedraz JL. Encapsulated cell technology: from research to market. Trends Biotechnol. 2002 Sep;20(9):38287.
54. De Vos P, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia. 2002;45:15973.
55. Prochorov AV, Tretjak SI, Roudenok VV, Goranov VA. Longterm normalization of diabetes mellitus after xenotransplantation of fetal pancreatic islet cells into the blood stream without immunosuppressive therapy. Transplant Proc. 2004 Nov;36(9):285556.
56. Elliott RB, Escobar L, Calafiore R, Basta G, Garkavenko O, Vasconcellos A, Bambra C. Transplantation of microand macroencapsulated piglet islets into mice and monkeys. Transplant Proc. 2005 Jan-Feb;37(1):46669.
57. Tibell A, Rafael E, Wennberg L, Nordenstrom J, Bergstrom M, Geller RL, Loudovaris T, Johnson RC, Brauker JH, Neuenfeldt S, Wernerson A. Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant. 2001;10(7):59199.Cell Transplant. 2001;10:591.
58. Colton CK. Implantable biohybrid arti?cial organs. Cell Transplant. 1995 Jul-Aug;4(4):41536.
59. Khryshchanovich V. Parathyroid cells allotransplantation in severe postsurgical hypoparathyroidism. Polish J of Surgery. 2011;(Supl. 1):S35.
60. Krol S, del Guerra S, Grupillo M, Diaspro A, Gliozzi A, Marchetti P. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett. 2006 Sep;6(9):193339.

Address for correspondence:
220116, Respublika Belarus', g. Minsk, pr-t. Dzerzhinskogo, d. 83, UO Belorusskii gosudarstvennyi meditsinskii universitet, 2-ia kafedra khirurgicheskikh boleznei,
Khryshchanovich Vladimir Ianovich
Information about the authors:
Khryshchanovich V.Ya., Doctor of Medical Sciences, Associate Professor of the 2nd Department of Surgical Diseases of EE Belarusian State Medical University." Tretyak S.I., Doctor of Medical Sciences, Professor, Head of the 2nd Department of Surgical Diseases of EE Belarusian State Medical University."
Contacts | ©Vitebsk State Medical University, 2007